ClassID:

95483

C07D497/10 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings Spiro-condensed systems

Recent Application in this class:
#1
20260152509
2026-06-04

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#2
20260062420
2026-03-05

NOVEL DPP1 INHIBITORS AND USES THEREOF

#3
20250243161
2025-07-31

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#4
20250115571
2025-04-10

OXOPIPERAZINE DERIVATIVES

#5
20240405271
2024-12-05

ADDITIVE FOR ELECTROLYTE OF LITHIUM BATTERY, ORGANIC ELECTROLYTE COMPRISING SAME AND LITHIUM BATTERY COMPRISING ELECTROLYTE

#6
20240356073
2024-10-24

ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME

#7
20240274884
2024-08-15

ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME

#8
20240246910
2024-07-25

Delivery of therapeutic alkaloid compounds

#9
20230391793
2023-12-07

METHOD OF PREPARING ORGANOSULFUR COMPOUND

#10
20230242808
2023-08-03

PHOTOCHROMIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC COMPOUND

#11
20230159455
2023-05-25

Delivery of therapeutic alkaloid compounds

#12
20230134334
2023-05-04

AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#13
20230133211
2023-05-04

PHOTOCHROMIC CYCLIC COMPOUND AND CURABLE COMPOSITION CONTAINING THE PHOTOCHROMIC CYCLIC COMPOUND

#14
20230133132
2023-05-04

NAMPT MODULATORS

#15
20230028687
2023-01-26

Quinolin-2-one derivatives

#16
20220213057
2022-07-07

Oxopiperazine derivatives

#17
20200308139
2020-10-01

Oxopiperazine derivatives

#18
20200190106
2020-06-18

Chromene compound, curable composition comprising the compound, and optical article including a cured body of the curable composition

#19
20200190055
2020-06-18

Quinolin-2-one derivatives

#20
20200190054
2020-06-18

Quinolin-2-one derivatives

#21
20190365931
2019-12-05

Double-labeled probe for molecular imaging and use thereof

#22
20190185449
2019-06-20

Oxopiperazine derivatives

#23
20190023685
2019-01-24

Quinolin-2-one derivatives

#24
20190020071
2019-01-17

Lithium battery

#25
20190020068
2019-01-17

Lithium battery

#26
20190020067
2019-01-17

Lithium battery

#27
20190020066
2019-01-17

Lithium battery

#28
20190020065
2019-01-17

Lithium battery

#29
20190020064
2019-01-17

Lithium battery

#30
20180265485
2018-09-20

Organo-1-oxa-4-azonium cyclohexane compounds

#31
20170237126
2017-08-17

Organic electrolytic solution and lithium battery including the same

#32
20160304462
2016-10-20

3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors

#33
20160304456
2016-10-20

3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors

#34
20150139908
2015-05-21

Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method

#35
20150110715
2015-04-23

Double-labeled probe for molecular imaging and use thereof

#36
20150005257
2015-01-01

Arylalkyloxy pyrimidine derivative, pesticide for agricultural and horticultural use containing arylalkyloxy pyrimidine derivative as active ingredient, and use of same

#37
20140154527
2014-06-05

Chromene compound

#38
20140093894
2014-04-03

Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

#39
20130130289
2013-05-23

Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

#40
20120157432
2012-06-21

Pyrrolidine derived beta 3 adrenergic receptor agonists

#41
20110237794
2011-09-29

Spiro Compounds And Methods Of Use

#42
20110236310
2011-09-29

LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD

#43
20110178055
2011-07-21

Dual NK1/NK3 receptor antagonists

#44
20110105470
2011-05-05

Lapachone compounds and methods of use thereof

#45
20100144735
2010-06-10

Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy

#46
20090137806
2009-05-28

Dual NK1/NK3 receptor antagonists

#47
20090105166
2009-04-23

Lapachone compounds and methods of use thereof

#48
20090060874
2009-03-05

BICYCLIC PYRROLIDINE DERIVATIVES

#49
20090022689
2009-01-22

C4-SPIRO-PYRROLIDINE ANTIVIRALS

#50
20080176763
2008-07-24

Collection of traceable compounds and uses thereof

#51
20080103230
2008-05-01

Spirotetrathiocarbamates and spirooxothiocarbamates

#52
20070167470
2007-07-19

Spiro compounds and methods of use

#53
20060204990
2006-09-14

Compounds and methods for fluorescent labeling

#54
20050143421
2005-06-30

Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy

#55
20050090533
2005-04-28

Dual NK1/NK3 receptor antagonists